Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000258620 is an uncharacterized lncRNA gene, annotated as a novel transcript located within an intron of the WD repeat domain 25 (WDR25) protein-coding gene. This transcript does not encode a protein and lacks evidence of involvement in drug mechanisms, disease roles, or established biological processes. It is cataloged mainly as a genomic feature rather than a therapeutic target. There is little data on its molecular classification beyond being a lncRNA, and its function, if any, remains undefined among available genetic databases[7][1][3]. This entry is likely used in annotation pipelines to denote a region of interest in genomic studies, not for pharmacological targeting. If you are seeking established molecular targets, protein-coding genes (such as WDR25 itself) provide more actionable information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, intronic to WD repeat domain 25 (ENSG00000258620).